Analysis of the interaction of extracellular matrix and phenotype of bladder cancer cells

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Dozmorov, Mikhail G ^a   Kyker, Kimberly D ^a   Saban, Ricardo ^a   Knowlton, Nicholas ^b   Dozmorov, Igor ^b   Centola, Michael B ^b   Hurst, Robert E ^a  

^a OKLAHOMA CITY UNIVERSITY   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FACTOR; COMPLEMENTARY DNA; MATRIGEL; PLASTIC; PROTEIN KINASE B; TRANSCRIPTION FACTOR; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE REGULATION; CELL GROWTH; CELL IMMORTALIZATION; CELL INTERACTION; CELL TYPE; CONTROLLED STUDY; DNA MICROARRAY; DRUG TARGETING; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GENE CLUSTER; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HYPOTHESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; UROTHELIUM;

EID: 32044435799     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-12     Document Type: Article

References (40)

1. Jernal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 2005, 55:10-30.
2. Amling CL: Diagnosis and management of superficial bladder cancer. Curr Probl Cancer 2001, 25:219-278.
3. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, Hawkins IR: Superficial bladder cancer: progression and recurrence. J Urol 1983, 130:1083-1086.
4. Smith BA, Kennedy WJ, Harnden P, Selby PJ, Trejdosiewicz LK, Southgate J: Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium. Cancer Res 2001, 61:1678-1685.
5. Syrigos KN, Harrington KJ, Pignatelli M: Role of adhesion molecules in bladder cancer. an important part of the jigsaw. Urology 1999, 53:428-434.
6. Rebel JM, Thijssen CD, Vermey M, Zwarthoff EC, van der Kwast TH: Modulation of intra-epithelial expansion of human T24 bladder-carcinoma cells in murine urotheliurn by growth factors and extracellular-matrix components. Int J Cancer 1995, 60:707-711.
7. Stoehr R, Zietz S, Burger M, Filbeck T, Denzinger S, Obermann EC, Hammerschmied C, Wieland WF, Knuechel R, Hartmann A: Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer. Eur Urol 2005, 47:58-63.
8. Bohle A, Jurczok A, Ardelt P, Wulf T, Ulmer AJ, Jocharn D, Brandau S: Inhibition of bladder carcinoma cell adhesion by oligopeptide combinations in vitro and in vivo. J Urol 2002, 167:357-363.
9. Hurst RE, Kyker KD, Bonner RB, Bowditch RG, Hemstreet GP: Matrix-Dependent Plasticity of the Malignant Phenotype of Bladder Cancer Cells. Anticancer Res 2003, 23:3119-3128.
10. Kyker KD, Culkin DJ, Hurst RE: A model for 3-dimensional growth of bladder cancers to study mechanisms of phenotypic expression. Urologic Oncology 2003, 21:255-261.
11. Dinney CP, Fishbeck R, Singh RK, Eve B, Pathak S, Brown N, Xie B, Fan D, Bucana CD, Fidler IJ: Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J Urol 1995, 154:1532-1538.
12. Hurst RE, Kamat CD, Kyker KD, Green DE, Ihnat MA: A novel multidrug resistance phenotype of bladder tumor cells grown on Matrigel or SIS gel. Cancer Lett 2005, 217:171-180.
13. Seth D, Gorrell MD, McGuinness PH, Leo MA, Lieber CS, McCaughan GW, Haber PS: SMART amplification maintains representation of relative gene expression: quantitative validation by real time PCR and application to studies of alcoholic liver disease in primates. J Biochem Biophys Methods 2003, 55:53-66.
14. Dozmorov I, Knowlton N, Tang Y, Shields A, Pathipvanich P, Jarvis JN, Centola M: Hypervariable genes-experimental error or hidden dynamics. Nucleic Acids Res 2004, 32:e147.
15. Dozmorov I, Knowlton N, Tang Y, Centola M: Statistical monitoring of weak spots for improvement of normalization and ratio estimates in microarrays. BMC Bioinformatics 2004, 5:53.
16. Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998, 95:14863-14868.
17. DAVID EASE. 2005.
18. GOTM. 2005.
19. Zhang B, Schmoyer D, Kirov S, Snoddy J: GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinformatics 2004, 5:16.:16.
20. Ingenuity Systems. 2005.
21. Chiang DY, Brown PO, Eisen MB: Visualizing associations between genome sequences and gene expression data using genome-mean expression profiles. Bioinformatics 2001, 17 Suppl 1:S49-S55.
22. Vadigepalli R, Chakravarthula , Zak DE, Schwaber JS, Gonye GE: PAINT: A Promoter Analysis and INteraction Network Generation Tool for Gene Regulatory Network Identification. OMICS. A Journal of Integrative Biology 2003, 7:235-252.
23. PAINT. 2005.
24. Kim J, Adam RM, Freeman MR: Trafficking of nuclear heparinbinding epidermal growth factor-like growth factor into an epidermal growth factor receptor-dependent autocrine loop in response to oxidative stress. Cancer Res 2005, 65:8242-8249.
25. Kirkegaard T, Witton CJ, McGlynn LM, Tovey SM, Dunne B, Lyon A, Bartlett JM: AKT activation predicts outcome in breast cancer patients treated with tamoxifen. J Pathol 2005, 207:139-146.
26. Iozzo RV: Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998, 67:609-652.
27. Kim JH, Shariat SF, Kim IY, Menesses-Diaz A, Tokunaga H, Wheeler TM, Lerner SP: Predictive value of expression of transforming growth factor-beta(1) and its receptors in transitional cell carcinoma of the urinary bladder. Cancer 2001, 92:1475-1483.
28. Ignotz RA, Massague J: Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986, 261:4337-4345.
29. Nesbit CE, Tersak JM, Prochownik EV: MYC oncogenes and human neoplastic disease. Oncogene 1999, 18:3004-3016.
30. Weaver V, Lelievre S, Lakins J, Chrenek M, Jones J, Giancotti F, Werb Z, Bissell M: beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2002, 2:205.
31. Entrez Gene 2005 [http://www,ncbi.nlm.nih.Igy/entrez/ query.fcgi?db=gene&cmd=Retrieve&dopt=fullreport&listuids= 9421].
32. Zacharatos P, Kotsinas A, Evangelou K, Karakaidos P, Vassiliou LV, Rezaei N, Kyroudi A, Kittas C, Patsouris E, Papavassiliou AG, Gorgoulis VG: Distinct expression patterns of the transcription factor E2F-I in relation to tumour growth parameters in common human carcinomas. J Pathol 2004, 203:744-753.
33. Steinhoff C, Prior A, Reichmann G, Seifert HH, Schulz WA: Activity of E2F-dependent promoters in bladder carcinoma cells and their use for tumour-specific targeting of p53-induced apoptosis. Int J Oncol 2002, 21:1033-1040.
34. Croft PR, Lathrop SL, Feddersen RM, Joste NE: Estrogen receptor expression in papillary urothelial carcinoma of the bladder and ovarian transitional cell carcinoma. Arch Pathol Lab Med 20O5, 129:194-199.
35. Waliszewski P, Waliszewska MK, Hemstreet GP, Hurst RE: Expression of Sex Steroid Receptor Genes and Co-Modulation with Retinoid Signaling in Normal Human Uroepithelial Cells and Bladder Cancer Cell Lines. Urol Oncol 1997, 3:141-147.
36. Kobayashi M, Sakai H, Hirata A, Yonemaru K, Yanai T, Watanabe K, Yamazoe K, Kudo T, Masegi T: Expression of myogenic regulating factors, Mlyogenin and MlyoD, in two canine botryoid rhabdomyosarcomas. Vet Pathol 2004, 41:275-277.
37. Watanabe K, Baba K, Saito A, Hoshi N, Suzuki T: Pseuclosarcomatous myofibroblastic tumor and myosarcoma of the urogenital tract. Arch Pathol Lab Med 2001, 125:1070-1073.
38. Tan PK, Downey TJ, Spitznagel ELJ, Xu P, Fu D, Dimitrov DS, Lempicki KA, Raaka BM, Cam MC: Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res 2003, 31:5676-5684.
39. Mor O, Nativ O, Stein A, Novak L, Lehavi D, Shiboleth Y, Rozen A, Berent E, Brodsky L, Feinstein E, Rahav A, Morag K, Rothenstein D, Persi N, Mor Y, Skaliter R, Regev A: Molecular analysis of transitional cell carcinoma using cDNA microarray. Oncogene 2003, 22:7702-7710.
40. Modlich O, Prisack HB, Pitschke G, Ramp U, Ackermann R, Bojar H, Vogeli TA, Grimm MO: Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles. Clin Cancer Res 2004, 10:3410-3421.